PB1926: REAL-WORLD ERYTHROPOIESIS-STIMULATING AGENT (ESA) TREATMENT PATTERNS AND OUTCOMES AMONG US PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS)
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000850556.55678.1f |
| _version_ | 1797288020116766720 |
|---|---|
| author | S. Mukherjee K. Zimmerman Savill A. Gajra J. Kish C. Brown-Bickerstaff D. Gentile A. Falkenstein T. Miller J. Laney A. McBride |
| author_facet | S. Mukherjee K. Zimmerman Savill A. Gajra J. Kish C. Brown-Bickerstaff D. Gentile A. Falkenstein T. Miller J. Laney A. McBride |
| author_sort | S. Mukherjee |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:43:15Z |
| format | Article |
| id | doaj.art-37b50b8ad7bf48938e47b8380298a3dc |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:43:15Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-37b50b8ad7bf48938e47b8380298a3dc2024-03-02T03:29:00ZengWileyHemaSphere2572-92412022-06-0161805180610.1097/01.HS9.0000850556.55678.1f202206003-01805PB1926: REAL-WORLD ERYTHROPOIESIS-STIMULATING AGENT (ESA) TREATMENT PATTERNS AND OUTCOMES AMONG US PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS)S. Mukherjee0K. Zimmerman Savill1A. Gajra2J. Kish3C. Brown-Bickerstaff4D. Gentile5A. Falkenstein6T. Miller7J. Laney8A. McBride91 Cleveland Clinic, Cleveland2 Cardinal Health Specialty Solutions, Dublin2 Cardinal Health Specialty Solutions, Dublin2 Cardinal Health Specialty Solutions, Dublin2 Cardinal Health Specialty Solutions, Dublin2 Cardinal Health Specialty Solutions, Dublin2 Cardinal Health Specialty Solutions, Dublin2 Cardinal Health Specialty Solutions, Dublin2 Cardinal Health Specialty Solutions, Dublin3 Bristol Myers Squibb, Princeton, United States of Americahttp://journals.lww.com/10.1097/01.HS9.0000850556.55678.1f |
| spellingShingle | S. Mukherjee K. Zimmerman Savill A. Gajra J. Kish C. Brown-Bickerstaff D. Gentile A. Falkenstein T. Miller J. Laney A. McBride PB1926: REAL-WORLD ERYTHROPOIESIS-STIMULATING AGENT (ESA) TREATMENT PATTERNS AND OUTCOMES AMONG US PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) HemaSphere |
| title | PB1926: REAL-WORLD ERYTHROPOIESIS-STIMULATING AGENT (ESA) TREATMENT PATTERNS AND OUTCOMES AMONG US PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) |
| title_full | PB1926: REAL-WORLD ERYTHROPOIESIS-STIMULATING AGENT (ESA) TREATMENT PATTERNS AND OUTCOMES AMONG US PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) |
| title_fullStr | PB1926: REAL-WORLD ERYTHROPOIESIS-STIMULATING AGENT (ESA) TREATMENT PATTERNS AND OUTCOMES AMONG US PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) |
| title_full_unstemmed | PB1926: REAL-WORLD ERYTHROPOIESIS-STIMULATING AGENT (ESA) TREATMENT PATTERNS AND OUTCOMES AMONG US PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) |
| title_short | PB1926: REAL-WORLD ERYTHROPOIESIS-STIMULATING AGENT (ESA) TREATMENT PATTERNS AND OUTCOMES AMONG US PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) |
| title_sort | pb1926 real world erythropoiesis stimulating agent esa treatment patterns and outcomes among us patients with lower risk myelodysplastic syndromes lr mds |
| url | http://journals.lww.com/10.1097/01.HS9.0000850556.55678.1f |
| work_keys_str_mv | AT smukherjee pb1926realworlderythropoiesisstimulatingagentesatreatmentpatternsandoutcomesamonguspatientswithlowerriskmyelodysplasticsyndromeslrmds AT kzimmermansavill pb1926realworlderythropoiesisstimulatingagentesatreatmentpatternsandoutcomesamonguspatientswithlowerriskmyelodysplasticsyndromeslrmds AT agajra pb1926realworlderythropoiesisstimulatingagentesatreatmentpatternsandoutcomesamonguspatientswithlowerriskmyelodysplasticsyndromeslrmds AT jkish pb1926realworlderythropoiesisstimulatingagentesatreatmentpatternsandoutcomesamonguspatientswithlowerriskmyelodysplasticsyndromeslrmds AT cbrownbickerstaff pb1926realworlderythropoiesisstimulatingagentesatreatmentpatternsandoutcomesamonguspatientswithlowerriskmyelodysplasticsyndromeslrmds AT dgentile pb1926realworlderythropoiesisstimulatingagentesatreatmentpatternsandoutcomesamonguspatientswithlowerriskmyelodysplasticsyndromeslrmds AT afalkenstein pb1926realworlderythropoiesisstimulatingagentesatreatmentpatternsandoutcomesamonguspatientswithlowerriskmyelodysplasticsyndromeslrmds AT tmiller pb1926realworlderythropoiesisstimulatingagentesatreatmentpatternsandoutcomesamonguspatientswithlowerriskmyelodysplasticsyndromeslrmds AT jlaney pb1926realworlderythropoiesisstimulatingagentesatreatmentpatternsandoutcomesamonguspatientswithlowerriskmyelodysplasticsyndromeslrmds AT amcbride pb1926realworlderythropoiesisstimulatingagentesatreatmentpatternsandoutcomesamonguspatientswithlowerriskmyelodysplasticsyndromeslrmds |